Audio Medica - Medical Audio News Interviews & Podcasts

British National Health Service is 60!

admin — Tue, 22 Jul 2008 12:42:21 +0000

Virginia Berridge

Virginia Berridge, Jerry Morris, Nick Mays, and Nick Black of The London School of Hygiene and Tropical Medicine
LSHTM Audio News
British National Health Service is 60!
July 5th, 2008 is the 60th birthday of the British National Health Service. Peter Goodwin talks to four experts at the London School of Hygiene and Tropical Medicine to find out how it achieved the almost universal approval it enjoys in the UK, while asking what the future holds in store.

Obesity, Car Travel, Climate Change: Linked?

admin — Wed, 11 Jun 2008 10:57:11 +0000

Phil Edwards

Phil Edwards, London School of Hyugiene and Tropical Medicine
LSHTM Audio News
Obesity Linked to Motor Transport And Climate Change
Peter Goodwin questions Phil Edwards of the London School of Hygiene and Tropical Medicine about “competition between stomachs and petrol tanks” discussed in a letter he and his colleague Ian Roberts have written to the medical magazine: The Lancet.

Audio Journal of Oncology Volume 16 Number 11

admin — Tue, 03 Jun 2008 23:49:20 +0000

Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)

Sarah Maxwell and Peter Goodwin report from: American Society of Clinical Oncology Annual Meeting, May 30-June 3, 2008, Chicago

Michael Gnant

In this edition:

1. Zoledronic Acid Reduces Recurrence In Early-Stage Breast Cancer

Michael Gnant, Medical University of Vienna, Austria
ABSTRACT: LBA4

2. Bevacizumab Slows Progression In Advanced Breast Cancer

David Miles, Mount Vernon Cancer Centre, London
ABSTRACT: LBA 1011

3. Discussion: Zoledronic Acid; Bevacizumab in Breast Cancer

Eric Winer, Dana-Farber Cancer Institute, Boston
ABSTRACT: LBA 4 & LBA 1011

4. Oral Capecitabine: Not For Older Patients with Early Breast Cancer

Hyman Muss, University of Vermont, Burlington
ABSTRACT: 507

5. Endometrial Cancer: Brachytherapy Is Better

Remi Nout, Leiden University Medical Center
ABSTRACT: LBA 5503

6. Adjuvant Gemcitabine Doubles Survival In Resected Pancreas Cancer

Helmut Oettle, Charité University, Berlin
ABSTRACT: LBA 4504

7. Everolimus Delays Metastatic Kidney Cancer Progression

Robert Motzer, Memorial Sloan-Kettering Cancer Center, New York
ABSTRACT: LBA 5026

8. Discussion: Gemcitabine For Pancreas Cancer; Brachytherapy for Endometrial Cancer

Nicholas Petrelli, Helen F Graham Cancer Center, Wilmington
ABSTRACTS: LBA 5503; LBA 4504; LBA5026

Buy Audio Journal of Oncology Digital Copy
Order Audio Journal of Oncology CD

Blind For Blindness: Preventing Childhood Blindness

admin — Wed, 28 May 2008 16:10:56 +0000

Hessom Razavi, Puneet Sayal, Claire Gilbert

Hessom Razavi, Puneet Sayal, Claire Gilbert, London School of Hygiene and Tropical Medicine
Eye doctor Hessom Razavi volunteered to go about his usual studies at the London School blindfold for 24 hours to give publicity to the need to prevent childhood blindness all over the world, especially in developing countries. The “Blind For Blindness” initiative was taken as part of the “Vision 2020″ project at the London School, with the help of Goodenough College, London.

Audio Journal of Oncology Volume 16 Number 10

admin — Sun, 25 May 2008 21:56:34 +0000

Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
Commenting Expert: Michael Untch, HELIOS Klinikum, Berlin

In this edition Peter Goodwin and Sara Freeman report from:
European Breast Cancer Conference, Berlin, April 15-19, 2008;
Chemotherapy Foundation Symposium, November 6-10, 2007, New York;
9th European Congress: Perspectives in Lung Cancer, Turin, March 14-15, 2008;
The Lancet, New England Journal of Medicine

Myron Czuczman

In this edition:

1. Lymphoma Immunotherapy: Anti-CD-80 Therapy With Galiximab

Myron Czuczman, Roswell Park Cancer Institute, Buffalo NY
Chemotherapy Foundation

2. Esophagogastric Cancer: Capecitabine First Line?

George Canellos, Dana-Farber Cancer Institute, Boston
N Engl J Med 358:1

3. Mammography: As Good For Older Patients

Jacques Fracheboud, Erasmus Medical Center, Rotterdam
EBCC , Berlin

4. Mammography: Three Year Interval Justified

Roger Blamey, Nottingham City Hospital

5. Mammography Assessed

Michael Untch, HELIOS Klinikum, Berlin

6. Colorectal Cancer: Add Chemo To Liver Mets Resection?

George Canellos, Dana-Farber Cancer Institute, Boston
Lancet 371:1007

7. Bevacizumab: New Standard for Non-Small Cell Lung Cancer?

Christian Manegold, Heidelberg University Medical Center, Manheim and Nick Thatcher, Christie Hospital, Manchester
European Lung Cancer Congress, Turin

8. Smoking And Death in India

George Canellos, Dana-Farber Cancer Institute, Boston
N Engl J Med 358:1137

Buy Audio Journal of Oncology Digital Copy
Order Audio Journal of Oncology CD

Audio Journal of Medicine

admin — Tue, 20 May 2008 02:17:05 +0000

In this edition:

1. Training In Depression And Suicide: Need For Change?

Stan Kutcher, Dalhousie University, Nova Scotia

2. Suicide Paradox Explained: Australian National Strategy

Barry Nurcombe, Princess Margaret Hospital, Perth

3. Methylphenidate in the Real World

Manfred Döpfner, University of Cologne

4. Long Acting ADHD Treatments: Not All The Same

David Coghill, University of Dundee

Ralph Littlejohn interviewed some of the key speakers at the 2008 international conference on child mental health.

Bivalirudin For Angioplasty: Expensive Heparin?

admin — Wed, 30 Apr 2008 13:26:56 +0000

Tony Gershlick

Tony Gershlick, University of Leicester
Adnan Kastrati, Deutsches Herzzentrum, Munich
Using bivalirudin instead of heparin during angioplasty wasn’t any better for preventing death, MI or urgent revascularisation in the 4,500-patient ISAR-REACT 3 study presented at the ACC annual meeting. Tony Gershlick and Adnan Kastrati discuss the study with Peter Goodwin and Sara Freeman.

Tropical Health Research: London Scientist Honored

admin — Tue, 29 Apr 2008 16:01:40 +0000

Brian Greenwood

Brian Greenwood, London School of Hygiene and Tropical Medicine
Brian Greenwood has won the Hideyo Noguchi Africa Prize for his numerous achievements in tropical disease research. He talked with Derek Thorne about his work, including the pivotal research proving that bed nets can help prevent malaria.

Audio Journal of Oncology Volume 16 Number 9

admin — Sat, 26 Apr 2008 11:35:44 +0000

Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
Commenting Expert: Emiel Rutgers, Netherlands Cancer Institute, Amsterdam

Angel Rodriguez

In this edition:

1. Lapatinib: Targets Breast Cancer Stem Cells?

Angel Rodriguez, Baylor College, Houston

2. No Help Adding Neoadjuvant Capecitabine

Gunter von Minckwitz, German Breast Group, Neu-Isenberg

3. MRI Aids Breast Surgery Planning

David Martinez-Cecilia, University Hospital Reina Sofia, Córdoba

4. Aromatase Inhibitors: No Extra Heart Risk

Alain Monnier, Centre Hospitalier de Belfort, Montbéliard

5. NAB Paclitaxel For Metastatic Breast Cancer?

William Gradishar, Northwestern University, Chicago

Peter Goodwin and Sara Freeman interview conference speakers in Berlin regarding lapatinib’s apparent effect on breast cancer “stem cells”; the lack of additional benefit from adding capecitabine to standard neoadjuvant chemotherapy; evidence that MRI improves surgical planning for breast cancer; news that aromatase inhibitors do not add to cardiovascular risk when used in adjuvant therapy instead of tamoxifen; and (from a satellite symposium) an assessment of the role of nanoparticle albumin-bound paclitaxel in therapy for metastatic breast cancer.

Audio Journal of Oncology Volume 16 Number 8

admin — Tue, 15 Apr 2008 23:05:54 +0000

Scientific Editors: George Canellos, Pat Price, Gordon McVie, Gianni Bonadonna

In this edition:

Bevacizumab and Survival in Metastatic Breast Cancer

Source: N Engl J Med 357:26
George Canellos, Dana-Farber Cancer Institute, Boston
Progresson-free survival, but not overall survival, was extended in patients with metastatic breast cancer who were randomly assigned to receive paclitaxel with bevacizumab as compared with paclitaxel alone.

Risks From Stopping Cancer Trials Early

Source: Annals of Oncology, April 9th, 2008
Giovanni Apolone, Mario Negri Institute, Milan
Stuart Pocock, London School of Hygiene and Tropical Medicine
New research highlights the dangers of stopping cancer clinical trials early following interim analysis before originally planned sample sizes have been reached, especially when surrogate end points are used.